ROBERTSON MICHELLE
Insider CIK 1755098 · MNTA Chief Financial Officer · VSTM Director · EDIT EVP, CHIEF FINANCIAL OFFICER · GERN EVP, Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VSTM Verastem, Inc. | A Award | 2026-05-21 | 2026-05-26 | 36,000 | — | $0 | 52,666 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2026-02-18 | 2026-02-19 | 27,500 | — | $0 | 82,500 | SEC↗ |
| GERN GERON CORP | M Exercise | 2026-02-18 | 2026-02-19 | 27,500 | — | $0 | 27,500 | SEC↗ |
| GERN GERON CORP | S Sale | 2026-02-18 | 2026-02-19 | 9,855 | $1.94 | $19.1K | 17,645 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2026-02-17 | 2026-02-19 | 1,660,000 | — | $0 | 1,660,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2025-05-22 | 2025-05-27 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2025-05-22 | 2025-05-27 | 8,333 | — | $0 | 16,666 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2025-02-18 | 2025-02-20 | 656,000 | — | $0 | 656,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2025-02-18 | 2025-02-20 | 110,000 | — | $0 | 110,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2024-06-18 | 2024-06-20 | 8,333 | — | $0 | 8,333 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2024-06-06 | 2024-06-07 | 250,000 | — | $0 | 250,000 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 5,291 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2024-03-11 | 2024-03-13 | 5,291 | — | $0 | 5,291 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2024-02-14 | 2024-02-16 | 850,000 | — | $0 | 850,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2023-09-25 | 2023-09-27 | 1,350,000 | — | $0 | 1,350,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2023-05-15 | 2023-05-16 | 62,500 | — | $0 | 62,500 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2023-05-11 | 2023-05-15 | 949 | $9.87 | $9.4K | 106,610 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2023-03-03 | 2023-03-06 | 184 | $8.89 | $1.6K | 107,559 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 94,500 | — | $0 | 94,500 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2023-03-02 | 2023-03-06 | 31,500 | — | $0 | 107,743 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2023-02-13 | 2023-02-15 | 4,287 | $9.67 | $41.5K | 76,243 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2023-01-10 | 2023-01-12 | 1,752 | $8.16 | $14.3K | 80,530 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2022-12-05 | 2022-12-06 | 193 | $10.23 | $2.0K | 82,282 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2022-09-06 | 2022-09-08 | 192 | $15.01 | $2.9K | 82,475 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 62,500 | — | $0 | 62,500 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2022-06-03 | 2022-06-06 | 1,527 | $11.54 | $17.6K | 82,667 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2022-05-12 | 2022-12-20 | 62,500 | — | $0 | 62,500 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2022-03-03 | 2022-03-07 | 767 | $17.33 | $13.3K | 84,194 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2022-02-10 | 2022-02-11 | 157,580 | — | $0 | 157,580 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2022-02-10 | 2022-02-11 | 53,499 | — | $0 | 84,961 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2022-01-11 | 2022-01-13 | 1,744 | $25.70 | $44.8K | 31,462 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2021-12-22 | 2021-12-23 | 4,471 | — | $0 | 33,206 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2021-11-15 | 2021-11-17 | 63,493 | — | $0 | 63,493 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2021-08-09 | 2021-08-10 | 2,500 | — | $0 | 115,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2021-08-09 | 2021-08-10 | 2,500 | $60.00 | $150.0K | 28,735 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2021-08-09 | 2021-08-10 | 2,500 | $30.65 | $76.6K | 31,235 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2021-06-28 | 2021-06-30 | 2,500 | — | $0 | 117,500 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2021-06-28 | 2021-06-30 | 2,500 | $50.00 | $125.0K | 28,735 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2021-06-28 | 2021-06-30 | 2,500 | $30.65 | $76.6K | 31,235 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2021-03-02 | 2021-03-04 | 32,197 | — | $0 | 32,197 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2021-03-02 | 2021-03-04 | 10,303 | — | $0 | 28,735 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2021-01-12 | 2021-01-13 | 1,568 | $78.27 | $122.7K | 18,432 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2020-01-09 | 2020-01-10 | 120,000 | — | $0 | 120,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2020-01-09 | 2020-01-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2019-10-25 | 2019-10-29 | 6,802 | $15.00 | $102.0K | 6,813 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2019-10-18 | 2019-10-21 | 2,936 | $13.83 | $40.6K | 13,615 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2019-10-17 | 2019-10-21 | 9,750 | — | $0 | 29,250 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2019-10-17 | 2019-10-21 | 9,750 | — | $0 | 16,551 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer | 2019-04-13 | 2019-04-16 | 4,725 | — | $0 | 6,801 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2019-02-14 | 2019-02-19 | 703 | $13.10 | $9.2K | 11,526 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2019-02-13 | 2019-02-14 | 1,410 | $12.70 | $17.9K | 12,229 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2019-02-12 | 2019-02-14 | 4,870 | — | $0 | 4,870 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2019-02-12 | 2019-02-14 | 4,870 | — | $0 | 13,639 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2019-02-11 | 2019-02-13 | 97,000 | — | $0 | 97,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2018-10-17 | 2018-10-19 | 39,000 | — | $0 | 39,000 | SEC↗ |